Primary Objective. Baseline measures of cognitive processing speed and executive function will predict employment deterioration over 12 to 24 months of follow-up.1a. In MS patients treated with ozanimod, studied at baseline and 12-24 months of follow-up, both the BAC-App and BICAMS will show sensitivity to MS cognitive impairment relative to HCs, with measures of cognitive p
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email firstname.lastname@example.org and someone will assist you.
Your information will be shared only with the research study team for recruitment purposes and designated CTSI personnel for project quality assurance and will remain confidential. Your information will be stored indefinitely. Should you no longer want this information to be provided in the aforementioned ways, please contact email@example.com.